Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2024-02-15 Fund Information / Fact…
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
113年1月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a revenue summary report for a company named 科妍, showing monthly and cumulative net operating revenue figures with percentage changes and explanations for the revenue changes. It is a brief financial data summary, not a full financial report or detailed analysis. The document length is short (791 characters), and it does not contain comprehensive financial statements or management discussion. It is essentially a factsheet or summary of key financial figures for a specific period (January 2024). Therefore, it fits best into the category of Fund Information / Factsheet (FS), which covers brief summaries of key company financials and market info.
2024-02-15 Chinese
113年01月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, managers, and their family members. It shows changes in share ownership, types of shares held, and other related data. There is no indication of financial statements, earnings data, or meeting materials. The content is focused on insider share transactions and holdings. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is substantive, not just an announcement or certification. Therefore, the appropriate classification is DIRS.
2024-02-05 Chinese
113年01月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by company insiders, including directors and senior management. It lists individual holdings, pledged shares, and related percentages. The content focuses on insider share transactions and holdings rather than financial results, management changes, or regulatory announcements. There is no indication of a report publication, earnings release, or management discussion. The document is a typical insider shareholding disclosure, which corresponds to Director's Dealing filings reporting personal share transactions by company directors and executives.
2024-02-05 Chinese
112年12月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 科妍, providing information about fund loans and endorsement guarantees for the current and previous months, with amounts all zero. It is a short, factual update without detailed financial statements or analysis. There is no indication of it being an annual or interim report, audit report, or any other detailed filing. The content fits the profile of a regulatory announcement or compliance disclosure rather than a full report. Given the short length and nature, it aligns best with Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2024-01-08 Chinese
112年12月營業收入
Fund Information / Factsheet Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 科妍, presented in a tabular format with percentage changes compared to the previous year. It includes notes explaining accounting standards and reporting practices related to IFRS and financial industry specifics. The document length is short (767 characters) and it does not contain detailed financial statements or comprehensive analysis. It appears to be a brief financial data summary rather than a full financial report or announcement. Given the nature and length, it fits best as a Fund Information / Factsheet (FS), which is a brief summary of key company financials and market info.
2024-01-08 Chinese
112年12月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, managers, and their related parties. It shows changes in shareholdings, types of shares held, and other related information. This type of document is typical of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but the actual disclosure of insider shareholdings and transactions. Therefore, the appropriate classification is Director's Dealing (DIRS).
2024-01-03 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.